在烟草使用障碍中,大麻的同时使用和内类固醇系统调节:一个翻译系统性审查和元分析
medRxiv : the preprint server for health sciences
|February 23, 2026
概括
同时使用大麻会阻碍戒烟,减少 35% 的戒烟成功率. 然而,针对性调节内分泌系统 (ECS),特别是使用大麻 (CBD),显示出改善戒烟结果的希望.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 烟草使用障碍 (TUD) 是可预防死亡的主要原因,目前的治疗方法显示长期成功有限.
- 扩大大麻合法化与增加的同时吸烟和大麻使用相吻合,这引发了关于它们在戒烟中的相互作用的问题.
- 内分泌系统 (ECS) 在TUD中的作用以及大麻共用对戒断结果的影响需要澄清.
研究的目的:
- 系统地审查和元分析同步使用大麻对戒烟的影响.
- 评估作为戒烟策略的内分泌大麻素系统 (ECS) 调节的临床前和临床证据.
主要方法:
- 按照PRISMA 2020指南进行的翻译系统审查和元分析.
- 搜索了主要的数据库 (MEDLINE,Embase,PsycInfo,Web of Science) 关于大麻的共同使用和戒断,大麻素调节剂和ECS向干预措施的研究.
- 包括观察性,临床前和人体实验研究;对符合条件的数据进行的元分析.
主要成果:
- 观察性研究 (N=229,630) 表明,同期使用大麻与戒烟几率减少35%有关 (OR=0.65).
- 临床前研究表明,CB1受体对抗剂减少了尼古丁摄入量,而大麻 (CBD) 则减少了尼古丁使用和戒断症状.
- 临床数据表明,与失败的CB1逆agonists不同,CBD减少了40%的香烟消费,逆转了提示诱导的注意偏差,并缓解了戒断.
结论:
- 自然主义的大麻暴露对戒烟成功产生了负面影响.
- 有针对性的ECS调节,特别是CBD,证明了戒烟的治疗潜力.
- 对于TUD治疗,CBD需要在足够强大的临床试验中进行进一步的研究.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
830
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
830
Substance Use Disorders Affecting Sleep
468
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
468
CNS Depressants: Alcohol and Nicotine
1.4K
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.4K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
974
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
974
Drug Dependence
1.8K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.8K
Drug Abuse and Addiction: Pharmacological Phenomena
1.3K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.3K


